Home > The lived experience of long COVID: a qualitative study of mental health, quality of life, and coping.

Kennelly, Colleen E and Nguyen, Anh T P and Sheikhan, Natasha Yasmin and Strudwick, Gillian and Ski, Chantal F and Thompson, David R and Bartram, Mary and Soklaridis, Sophie and Rossell, Susan L and Castle, David and Hawke, Lisa D (2023) The lived experience of long COVID: a qualitative study of mental health, quality of life, and coping. PLoS ONE, 18, (10), e0292630. doi: 10.1371/journal.pone.0292630.

External website: https://journals.plos.org/plosone/article?id=10.13...

The majority of people who contract COVID-19 experience a short period of symptomatic infection. However, symptoms persist for months or years following initial exposure to the virus in some cases. This has been described as long COVID. Little is known about the lived experience of this condition, as it has only recently emerged. This study aimed to explore the experiences of mental health, quality of life, and coping among people living with long COVID. A sample of 47 adults with lived experience participated in web-based focus groups. Separate focus groups were held for 24 individuals with pre-existing mental health conditions and 23 individuals without pre-existing mental health conditions. Data were analyzed using a codebook thematic analysis approach. Five themes were identified as integral to the long COVID experience: The Emotional Landscape of Long COVID, New Limits to Daily Functioning, Grief and Loss of Former Identity, Long COVID-related Stigmatization, and Learning to Cope with Persisting Symptoms. These findings illustrate the immense impact of long COVID on mental health and quality of life. Minimal differences were found between those with and those without pre-existing mental health conditions, as both groups were substantially impacted by the condition. Attention to the perspectives of people with lived experience of long COVID is necessary to inform future directions for research and clinical practice.


Item Type
Article
Publication Type
International, Open Access, Article
Drug Type
All substances
Intervention Type
Harm reduction
Date
2023
Identification #
doi: 10.1371/journal.pone.0292630
Publisher
Public Library of Science
Volume
18
Number
10
EndNote

Repository Staff Only: item control page